Bruker BioSpin Newsletter #15

Congratulations to This Year's Winners of the Richard E. Ernst Prize Award

Congratulations to Prof. Andrew Webb from the Gorter MRI Center at the Leiden University Medical Center (LUMC), The Netherlands, and Prof. Bernhard Blümich from the Institute of Technical and Macromolecular Chemistry, 德国亚琛工业大学 , Germany, for winning this year’s Richard R. Ernst Prize in Magnetic Resonance at the 2024 Euromar Conference! The Richard R. Ernst Prize was founded by Euromar with sponsorship by Bruker in 2016 and represents a significant recognition in the field of magnetic resonance research and its practical applications.

From left to right, Dr. Oscar Millet , Member of the 2024 Ernst Prize Committee; Winner: Prof. Andrew Webb; Winner: Prof. Bernhard Blümich; Till Kuehn , Bruker

Read more: https://goto.bruker.com/46q92xc

Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, Germany

Bruker is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, Germany. This ultra-high field NMR system positions FMP among leading institutions worldwide with access to 1.2 GHz NMR, enabling breakthrough biomolecular research. We are honored to contribute to such invaluable work and look forward to the scientific and medical discoveries that FMP's research will bring to society.

Learn more: https://goto.bruker.com/3RS5iOG

Photographer: Silke O?wald ?

f.l.t.r.: Dr. Peter Schmieder , Prof. Dr. Han Sun , Prof. Dr. Adam Lange, Dr. Sigrid Milles , Prof. Dr. Hartmut Oschkinat

Brand-New Office Space in the United Kingdom

Bruker is thrilled to share some fantastic news with you! The beginning of this year marked a momentous milestone for us as we embarked on a journey to a brand-new office space in the United Kingdom. This move signifies a significant step forward in our commitment to delivering unparalleled service and fostering even stronger relationships within the UK and beyond. We can't wait to unveil the details of our new home and the opportunities it brings. Stay tuned for an inside look at our cutting-edge space and the bright future ahead!

Find out more about the UK office: https://goto.bruker.com/4cbAfVw

Decoupling: High Resolution and Sensitivity

Two important factors in one-dimensional NMR spectroscopy are high resolution and sensitivity. Both can be more than doubled when using heteronuclear decoupling, which allows for the separation of overlapping signals as demonstrated for analysis of diluted components in reaction mixtures. Learn more in our free whitepaper "Decoupling: The Key to High Resolution and Sensitivity in One-Dimensional NMR Spectra"

Download it now: https://goto.bruker.com/4dq7PYL

Estonia Takes a Stand Against Honey Adulteration with NMR Technology

The Estonian honey market has seen significant advancements due to the adoption of Nuclear Magnetic Resonance (NMR) as the main analysis technique:

• Estonia has a rich beekeeping tradition with beekeepers like Taavi Tull and Peeter Matson who are both dedicated to producing authentic honey.
• The market has faced challenges with adulteration in the past, where cheaper sugar syrups are sold as “real” honey, impacting both consumer trust and the livelihood of genuine beekeepers.

Overall, NMR has proven to be a valuable tool in maintaining the quality and reputation of Estonian honey, ensuring that the market remains clear of adulterated products and that consumers can enjoy the true taste of pure honey.

Read here the stories of players from the Estonian Market: https://goto.bruker.com/3Wn4Jy5

Spectrospin AG and the World’s First Fully Transistorized NMR Spectrometer

In June 1965, Prof. Dr Günther Laukien founded Spectrospin AG in Zurich-Altstetten together with Swiss NMR specialists Dr Werner Tschopp and Dr Tony W. Keller. In 1967, just two years after its founding, Spectrospin AG introduced the world’s first fully transistorized #NMR spectrometer, the HFX-90, to the market. Here is an HFX-90 from 1971.

We look to the future, but without forgetting where we come from.

Read more: https://goto.bruker.com/4cTj0JP

Bruker and the ISMRM Community: Fostering Inspiring Preclinical MRI Science

The work of the ISMRM and the collaborations that it inspires truly make a difference in the role that magnetic resonance plays in the medical world. Many of the scientific revolutions that are changing the way we see the world have their origin in preclinical research. We hosted some of the brightest minds in preclinical imaging today at our Bruker Scientific Workshop at the ISMRM conference in Singapore this year. All of those incredible talks are now available for on-demand viewing.

Register now: https://goto.bruker.com/3WHVREm

Benchtop NMR for Quality Control

Nuclear Magnetic Resonance (NMR) is renowned for its precision in structural analysis and quantitative results, a staple in R&D for years. The advent of benchtop systems like the Bruker Fourier 80 has made NMR even more appealing for quality control, especially within the Analytical Quality By Design framework. NMR's versatility and robustness make it ideal for both qualitative and quantitative release tests, covering a wide range of applications from raw material control to final drug product testing. The Fourier 80, in particular, offers a maintenance-free, cryogen-free solution that simplifies the implementation of NMR procedures in quality control laboratories. Combined with the Bruker GxP solutions, they allow for streamlined analytical procedures in full compliance with pharmaceutical regulations.

Download our free application notes: https://goto.bruker.com/3YlE8Ed

Purchase on Invoice

Good news, we have expanded our payment options in the Bruker Store for Magnetic Resonance and Preclinical Imaging to all countries worldwide! In addition to the credit card, you can now complete your purchases using Purchase on Invoice.

Read more: https://goto.bruker.com/3yuPzi9

Enabling Collaboration Anytime and Anywhere*

Thanks to the strict standardization of the Bruker Avance IVDr platform and the highest reproducibility and data quality from sample to sample and instrument to instrument under full automation, all data and results can be shared among research groups worldwide anytime and anywhere and can be used for common data analysis.

Read more: https://goto.bruker.com/3A11moV

*Research use only. Bruker NMR instruments are not intended for use in clinical diagnostic procedures.

Harmonised Methods Transfer from R&D to QC lab: Would This Help?

Both, the transfer of R&D testing methods to manufacturing testing methods and the validation of the latter by the first one significantly reduces the time-to-market of new products. Methods that are developed in an R&D environment with the Avance series instrument can be effortlessly transferred into the manufacturing environment on benchtop Fourier units.

Download the free ebook: https://goto.bruker.com/3WLwYbb